EKB Journal Management System

176.

Evolution of treatment of chronic hepatitis C virus infection by directly acting anti-viral therapeutics: A glimmer of hope

Volume 1.1, Issue 1, November 2015, Pages 1-11
Abd-Elkhalek E.; Kamal A.; Helmy A.

177.

PREVALENCE OF HEPATITIS C INFECTION AMONG DIABETICS TYPE 2 AT SHARKIA GOVERNORATE, EGYPT

Volume 21, Issue 1, January 2015, Pages 1-10
Essam Amin; Adel Ghorab; Mohamed Mohamed; Amal Zidan

178.

Osteoporosis in Chronic Hepatitis C

Volume 4, Issue 3, September 2014, Pages 126-135
Abeer H Abdelkader; Ibraheem H Hegazy; Elased G Elbadrawy; Ayman F Zeid; Jihan A Shawky; Soha A El-Hawary; Amal A Jouda; Mohamed H Emara

179.

TYPES AND PREDICTORS OF INTERFERON/RIBAVIRIN INDUCED CARDIAC COMPLICATIONS IN THE EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS

Volume 20, Issue 5, September 2014, Pages 1-11
Ibtesam El-Dosouky; Soha ElHawari; Mohamed Emara; Emad Hamed

180.

Nutritional Assessment For Patients With Hepatitis C Virus In The Compensated Stage

Volume 1, Issue 2, July 2014, Pages 45-61
Hanan Mohamed Badran; Soheir Mohamed Weheida; Amany Mohamed Shebl Abd Ellateef; Amira Ahmed Hassanein; Gamal El-Sayed Shiha

181.

THE RELATIONSHIP BETWEEN INSULIN RESISTANCE AND HEPATITIS C VIRUS INFECTION IN EGYPTIAN PATIENTS

Volume 2014, Issue 6, June 2014, Pages 17-26
Samir Zaahkouk; Samir A. Zaahkouk; Olfat M. Hendy; Hesham G. Abd El- Rasheid; Gamal H. Allaithy

182.

Synergistic Effect of Schistosomiasis on Hepatitis C Virus (HCV) of Human Liver Indicated by Antioxidant Biomarkers among Egyptian Population

Volume 2, Issue 1, 2013, Pages 81-88
Z. I. Nabil; G. A. Abd-Allah; N. A. Omar; A. A. Kandeel

183.

Prevalence of Non Organ-Specific Auto Antibodies and its Effect on Response to Antiviral Therapy in Patients with Chronic Hepatitis C Virus Genotype 4

Volume 3, Issue 2, June 2013, Pages 34-42
Mohamed Abd El-Maksoud; Hatem Elalfy; Maha Ragab Habeeb; Abd-Elmohsen E El-desoky; Ziyad M Tawhid; Basem S Eldeek

184.

Efficacy of Ribavirin to Prevent Hepatitis Reactivation in Hepatitis C Virus-infected Patients Treated for Non-Hodgkin Lymphoma

Volume 3, Issue 1, March 2013, Pages 17-26
Fouad M Abo-Taleb; Ashraf M El-Hefeni; Ahmed Kotb; Tarek A El-Gohary

185.

The Role of Interleukin-18 Promoter Polymorphisms ( -607 C/A and 137 G/C ) in Determining HCV Clearance or Persistence.

Volume 50, Issue 1, January 2013, Pages 141-149
Saadia Farid; Laila Rashid; Samya Swelam

186.

Adiponectin and interlukin-10 in patients with liver diseases before and after liver transplantation

Volume 44, Issue 1, July 2011, Pages 318-324
Abdelgawad A. Fahmi; Mohamed A. El-Desouky; Mohamed M. El Gamal; Mohamed M. El Gamal

187.

Immunoparasitological Study in Bilharzial Patients With or without Hepatitis C Virus in El-Beheira Governorate

Volume 37, Issue 3, July 2007, Pages 690-710
Safaa M. Eassa; Moustafa El-Fadly; Sanaa A. El-Masry; Zeinab Shaibat El-Hamd

188.

Serum Level of Aflatoxin B1 in Hepatitis C Virus Infected Patients in Alexandria, Egypt, with or without Cirrhosis and HCC

Volume 36, Issue 4, October 2006, Pages 1037-1046
Sherif R. Omar; Ezzat M. Hassan; Magdy A. Mohamed; Suzan A. Abou-Gouneime

First Page Previous Page 1 2 3 4 5 6 7 8 Next Page Last Page